Freedman Financial Associates’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-100
Closed -$5K 451
2022
Q1
$5K Hold
100
﹤0.01% 418
2021
Q4
$6K Hold
100
﹤0.01% 380
2021
Q3
$6K Hold
100
﹤0.01% 394
2021
Q2
$6K Hold
100
﹤0.01% 387
2021
Q1
$6K Hold
100
0.01% 391
2020
Q4
$5K Buy
+100
New +$4.93K ﹤0.01% 398

Other funds holding XRAY

Freedman Financial Associates's XRAY Position: Q2 2022 in Review

Freedman Financial Associates sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 100 shares — an estimated $5K sold.

Freedman Financial Associates first reported a position in XRAY in Q4 2020 and held it in 6 quarters. The position peaked at $6K in Q4 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Freedman Financial Associates reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 100 Dentsply Sirona shares in Q2 2022, an estimated $5K.
  • Freedman Financial Associates first reported a position in Dentsply Sirona in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Dentsply Sirona position peaked at $6K in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.